Talking to ET Now, Abhimanyu Sofat, IIFL, says from a valuation perspective, if you get stocks at multiples of around 9-9.5, then these can be accumulated and made part of the portfolio. What is the call on some of the consumer names especially ITC ahead of numbers?
For More Details Visit-
via Would rather be a contra buyer in IT than pharma: Abhimanyu Sofat, IIFL
No comments:
Post a Comment